New drugs in the treatment of multiple myeloma

Medicina clínica
Albert Oriol, Cristina Motlló

Abstract

Progress in the treatment of multiple myeloma in the last decade has been able to delay, but ultimately not to prevent, the development of resistances and most patients still die of the disease or its related complications. New drugs have been developed including new alkylating agents, proteasome inhibitors and immunomodulators but also monoclonal antibodies and drugs with new mechanisms of action. Hopefully, this new generation of targeted agents will improve the results of the initial therapy, avoid relapses and development of resistances and provide better and less toxic options for the relapsed and refractory patient.

References

Nov 24, 1999·The New England Journal of Medicine·S SinghalB Barlogie
Mar 20, 2004·Lancet·Bhawna Sirohi, Ray Powles
Apr 20, 2004·Blood·Teru HideshimaKenneth C Anderson
May 4, 2004·Nature Reviews. Cancer·Julian Adams
Oct 29, 2004·The New England Journal of Medicine·Robert A Kyle, S Vincent Rajkumar
Oct 20, 2005·Blood·Constantine S MitsiadesKenneth C Anderson
Jul 10, 2007·Cancer Research·Susan D DemoMark K Bennett
Nov 23, 2007·The New England Journal of Medicine·Meletios DimopoulosUNKNOWN Multiple Myeloma (010) Study Investigators
Nov 23, 2007·The New England Journal of Medicine·Donna M WeberUNKNOWN Multiple Myeloma (009) Study Investigators
Nov 29, 2007·Future Oncology·R Donald Harvey, Sagar Lonial
Jan 25, 2008·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Conor D Collins
Apr 23, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jesús San-MiguelKenneth C Anderson
May 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eric D HsiMarna B Williams
Nov 14, 2008·Leukemia·A Palumbo, S V Rajkumar
Dec 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Julie A McEarchernChe-Leung Law
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ashraf BadrosSteven Grant
Mar 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kenneth C Anderson
Aug 20, 2011·Leukemia·N W C J van de DonkH M Lokhorst
Oct 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul G RichardsonKenneth C Anderson
Feb 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joan BladéLaura Rosiñol
Feb 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrzej J JakubowiakKenneth C Anderson
May 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sagar LonialSundar Jagannath
Mar 20, 2013·European Journal of Haematology·Alessandro AllegraCaterina Musolino

❮ Previous
Next ❯

Citations

Jul 11, 2014·Plant & Cell Physiology·Marc GallandLoïc Rajjou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.